DIETARY MODULATION OF CELL CYCLE REGULATORS

细胞周期调节剂的饮食调节

基本信息

  • 批准号:
    2468415
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The cyclin-dependent kinase inhibitors are a recently characterized class of proteins that regulate cell number homeostasis and progression of the cell cycle. One of these, p21(WAF1/CIP1), can be transcriptionally activated by the tumor suppressor p53 (especially in response to DNA damage) and so links regulation of the cell cycle and tumorigenesis. Transcription of p21 can also be induced independently of p53. One effect of p21 is to cause an arrest of the cell cycle at the G1 phase; depending on the cell type, this G1 arrest can allow time for repair of damaged DNA or lead to apoptotic death. Cells that lack p53 function cannot induce p53-dependent expression of p21 and display increased genomic instability and decreased cell cycle transit time. Following up on the link between p53 and p21, we examined the expression of p21 in the p53-"knockout" mouse and showed that dietary modifications that significantly delay the inevitable development of spontaneous tumors in this model also modulate p21 expression. Among these successful manipulations is dietary administration of dehydroepiandrosterone (DHEA), an adrenal steroid with global metabolic effects in addition to its chemopreventive activity. To study the effects of various agents on expression of cell cycle regulators more directly in an in vitro model system, we have developed embryonic fibroblast cell lines from fetuses with or without p53. In this system DHEA indeed slowed the cell cycle, even in p53-deficient cells, but had no direct effect on genomic stability, as assessed by the appearance of chromosomal aneuploidy and polyploidy. We are currently developing p21 constructs to investigate the possibility that some of the other actions of DHEA may require the induction of p21. These constructs will also be used to address more general questions concerning the role of p21 in regulation of metabolism.
周期蛋白依赖性激酶抑制剂是最近发现的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S N PERKINS其他文献

S N PERKINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S N PERKINS', 18)}}的其他基金

NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3838276
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY MODULATION OF CELL CYCLE REGULATORS
细胞周期调节剂的饮食调节
  • 批准号:
    6160848
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY MODULATION OF CELL CYCLE REGULATORS
细胞周期调节剂的饮食调节
  • 批准号:
    6100748
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3774731
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    5201400
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3752553
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3853374
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The role of the APC-E3-ligase in DNA repair and apoptosis
APC-E3 连接酶在 DNA 修复和细胞凋亡中的作用
  • 批准号:
    564771-2021
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
The role of the APC-E3-ligase in DNA repair and apoptosis
APC-E3 连接酶在 DNA 修复和细胞凋亡中的作用
  • 批准号:
    551553-2020
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    8065522
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    7661914
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    8268502
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
  • 批准号:
    7848344
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Role of PTHrP in DNA repair and cellular apoptosis on cancer cells
PTHrP 在癌细胞 DNA 修复和细胞凋亡中的作用
  • 批准号:
    nhmrc : 448338
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
    NHMRC Postgraduate Scholarships
Modulation of p53-induced cell cycle progression, DNA repair and apoptosis by HCV gene expression.
HCV 基因表达调节 p53 诱导的细胞周期进程、DNA 修复和细胞凋亡。
  • 批准号:
    08457163
  • 财政年份:
    1996
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
DNA 修复、细胞周期检查点和细胞凋亡作为抗癌药物的靶点
  • 批准号:
    10925958
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
DNA 修复、细胞周期检查点和细胞凋亡作为抗癌药物的靶点
  • 批准号:
    10262019
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了